| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | carbamoyl-phosphate synthase (ammonia) activity | 1.63e-05 | 2 | 81 | 2 | GO:0004087 | |
| GeneOntologyMolecularFunction | carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity | 1.63e-05 | 2 | 81 | 2 | GO:0004088 | |
| GeneOntologyMolecularFunction | alpha-amylase activity | 1.61e-04 | 5 | 81 | 2 | GO:0004556 | |
| GeneOntologyMolecularFunction | amylase activity | 2.41e-04 | 6 | 81 | 2 | GO:0016160 | |
| Domain | FN3_dom | PAPPA2 NPHS1 FLNC FNDC1 NEO1 IGF1R MYLK PTPRK AXL IL20RA NFASC ROBO2 ROS1 USH2A IL5RA | 6.24e-15 | 209 | 77 | 15 | IPR003961 |
| Domain | FN3 | PAPPA2 NPHS1 FLNC FNDC1 NEO1 IGF1R MYLK PTPRK AXL NFASC ROBO2 ROS1 USH2A | 6.11e-13 | 185 | 77 | 13 | SM00060 |
| Domain | FN3 | NPHS1 FNDC1 NEO1 IGF1R MYLK PTPRK AXL IL20RA NFASC ROBO2 ROS1 USH2A IL5RA | 1.56e-12 | 199 | 77 | 13 | PS50853 |
| Domain | fn3 | NPHS1 FNDC1 NEO1 IGF1R MYLK PTPRK AXL NFASC ROBO2 ROS1 USH2A | 6.06e-11 | 162 | 77 | 11 | PF00041 |
| Domain | - | PAPPA2 NPHS1 FLNC FNDC1 NEO1 IGF1R MYLK HMCN1 PTPRK AXL IL20RA NFASC ROBO2 ROS1 USH2A IL5RA | 9.68e-09 | 663 | 77 | 16 | 2.60.40.10 |
| Domain | Ig-like_fold | PAPPA2 NPHS1 FLNC FNDC1 NEO1 IGF1R MYLK HMCN1 PTPRK AXL IL20RA NFASC ROBO2 ROS1 USH2A IL5RA | 2.33e-08 | 706 | 77 | 16 | IPR013783 |
| Domain | Ig_I-set | 1.14e-06 | 190 | 77 | 8 | IPR013098 | |
| Domain | I-set | 1.14e-06 | 190 | 77 | 8 | PF07679 | |
| Domain | CPSase_sm_chain | 1.68e-05 | 2 | 77 | 2 | PF00988 | |
| Domain | CPSase_L_D3 | 1.68e-05 | 2 | 77 | 2 | PF02787 | |
| Domain | CarbamoylP_synth_ssu | 1.68e-05 | 2 | 77 | 2 | IPR006274 | |
| Domain | CarbamoylP_synth_lsu | 1.68e-05 | 2 | 77 | 2 | IPR006275 | |
| Domain | - | 1.68e-05 | 2 | 77 | 2 | 3.50.30.20 | |
| Domain | CPSase_sm_chain | 1.68e-05 | 2 | 77 | 2 | SM01097 | |
| Domain | CPSase_L_D3 | 1.68e-05 | 2 | 77 | 2 | SM01096 | |
| Domain | CbamoylP_synth_lsu_CPSase_dom | 1.68e-05 | 2 | 77 | 2 | IPR005483 | |
| Domain | CarbamoylP_synth_lsu_oligo | 1.68e-05 | 2 | 77 | 2 | IPR005480 | |
| Domain | - | 1.68e-05 | 2 | 77 | 2 | 1.10.1030.10 | |
| Domain | CarbamoylP_synth_ssu_N | 1.68e-05 | 2 | 77 | 2 | IPR002474 | |
| Domain | MGS | 5.02e-05 | 3 | 77 | 2 | SM00851 | |
| Domain | MGS-like_dom | 5.02e-05 | 3 | 77 | 2 | IPR011607 | |
| Domain | A-amylase_C | 5.02e-05 | 3 | 77 | 2 | IPR031319 | |
| Domain | MGS | 5.02e-05 | 3 | 77 | 2 | PF02142 | |
| Domain | - | 5.02e-05 | 3 | 77 | 2 | 3.40.50.1380 | |
| Domain | LamGL | 1.00e-04 | 4 | 77 | 2 | SM00560 | |
| Domain | Neural_cell_adh | 1.00e-04 | 4 | 77 | 2 | IPR009138 | |
| Domain | Aamy_C | 1.00e-04 | 4 | 77 | 2 | SM00632 | |
| Domain | Alpha_amylase | 1.00e-04 | 4 | 77 | 2 | IPR006046 | |
| Domain | LamG-like | 1.00e-04 | 4 | 77 | 2 | IPR006558 | |
| Domain | Alpha-amylase_C | 1.66e-04 | 5 | 77 | 2 | PF02806 | |
| Domain | GATase | 1.66e-04 | 5 | 77 | 2 | PF00117 | |
| Domain | A-amylase/branching_C | 1.66e-04 | 5 | 77 | 2 | IPR006048 | |
| Domain | CPSASE_1 | 1.66e-04 | 5 | 77 | 2 | PS00866 | |
| Domain | GATASE | 2.49e-04 | 6 | 77 | 2 | IPR017926 | |
| Domain | Glyco_hydro_13 | 2.49e-04 | 6 | 77 | 2 | IPR015902 | |
| Domain | CPSASE_2 | 2.49e-04 | 6 | 77 | 2 | PS00867 | |
| Domain | GATASE_TYPE_1 | 2.49e-04 | 6 | 77 | 2 | PS51273 | |
| Domain | IG | 3.37e-04 | 421 | 77 | 8 | SM00409 | |
| Domain | Ig_sub | 3.37e-04 | 421 | 77 | 8 | IPR003599 | |
| Domain | Aamy | 3.48e-04 | 7 | 77 | 2 | SM00642 | |
| Domain | CPSase_L_D2 | 3.48e-04 | 7 | 77 | 2 | PF02786 | |
| Domain | Glyco_hydro_13_cat_dom | 3.48e-04 | 7 | 77 | 2 | IPR006047 | |
| Domain | CbamoylP_synth_lsu-like_ATP-bd | 3.48e-04 | 7 | 77 | 2 | IPR005479 | |
| Domain | BC-like_N | 3.48e-04 | 7 | 77 | 2 | IPR005481 | |
| Domain | Biotin_carb_N | 3.48e-04 | 7 | 77 | 2 | PF00289 | |
| Domain | Alpha-amylase | 3.48e-04 | 7 | 77 | 2 | PF00128 | |
| Domain | IGc2 | 4.19e-04 | 235 | 77 | 6 | SM00408 | |
| Domain | Ig_sub2 | 4.19e-04 | 235 | 77 | 6 | IPR003598 | |
| Domain | ZINC_PROTEASE | 7.19e-04 | 98 | 77 | 4 | PS00142 | |
| Domain | - | 7.39e-04 | 10 | 77 | 2 | 3.40.50.880 | |
| Domain | - | 9.01e-04 | 11 | 77 | 2 | 2.40.155.10 | |
| Domain | GFP-like | 9.01e-04 | 11 | 77 | 2 | IPR023413 | |
| Domain | Tyr_kinase_rcpt_2_CS | 9.01e-04 | 11 | 77 | 2 | IPR002011 | |
| Domain | IG_LIKE | 9.26e-04 | 491 | 77 | 8 | PS50835 | |
| Domain | RECEPTOR_TYR_KIN_II | 1.08e-03 | 12 | 77 | 2 | PS00239 | |
| Domain | Class_I_gatase-like | 1.08e-03 | 12 | 77 | 2 | IPR029062 | |
| Domain | Ig-like_dom | 1.08e-03 | 503 | 77 | 8 | IPR007110 | |
| Domain | ig | 1.13e-03 | 190 | 77 | 5 | PF00047 | |
| Domain | Immunoglobulin | 1.13e-03 | 190 | 77 | 5 | IPR013151 | |
| Domain | - | 1.27e-03 | 13 | 77 | 2 | 3.40.50.20 | |
| Domain | - | 1.48e-03 | 14 | 77 | 2 | 2.60.40.1180 | |
| Domain | ATP-grasp | 1.48e-03 | 14 | 77 | 2 | IPR011761 | |
| Domain | PreATP-grasp_dom | 1.48e-03 | 14 | 77 | 2 | IPR016185 | |
| Domain | ATP_GRASP | 1.48e-03 | 14 | 77 | 2 | PS50975 | |
| Domain | Glyco_hydro_b | 1.70e-03 | 15 | 77 | 2 | IPR013780 | |
| Domain | - | 1.70e-03 | 15 | 77 | 2 | 3.30.1490.20 | |
| Domain | ATP_grasp_subdomain_1 | 2.46e-03 | 18 | 77 | 2 | IPR013815 | |
| Domain | - | 2.46e-03 | 18 | 77 | 2 | 3.30.470.20 | |
| Pathway | REACTOME_DIGESTION | 1.68e-06 | 21 | 60 | 4 | MM15526 | |
| Pathway | REACTOME_DIGESTION | 2.47e-06 | 23 | 60 | 4 | M27790 | |
| Pathway | REACTOME_DIGESTION_AND_ABSORPTION | 3.51e-06 | 25 | 60 | 4 | MM15557 | |
| Pathway | REACTOME_DIGESTION_AND_ABSORPTION | 5.62e-06 | 28 | 60 | 4 | M27837 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_LIPID | 2.64e-04 | 6 | 60 | 2 | MM14738 | |
| Pathway | KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM | 3.33e-04 | 32 | 60 | 3 | M17758 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_LIPID | 3.69e-04 | 7 | 60 | 2 | M27069 | |
| Pathway | SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES | 4.35e-04 | 35 | 60 | 3 | M16801 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 4.91e-04 | 8 | 60 | 2 | MM14717 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION_AMYLASE_ | 6.29e-04 | 9 | 60 | 2 | M47622 | |
| Pathway | REACTOME_CELL_CELL_COMMUNICATION | 7.36e-04 | 96 | 60 | 4 | MM14592 | |
| Pubmed | The ubiquitin ligase Ubr4 controls stability of podocin/MEC-2 supercomplexes. | 6.05e-07 | 69 | 81 | 5 | 26792178 | |
| Pubmed | Common variants conferring risk of schizophrenia: a pathway analysis of GWAS data. | 1.44e-06 | 10 | 81 | 3 | 20659789 | |
| Pubmed | 1.44e-06 | 10 | 81 | 3 | 12101187 | ||
| Pubmed | Evolution of the mammalian G protein alpha subunit multigene family. | 5.34e-06 | 49 | 81 | 4 | 1302014 | |
| Pubmed | The action of human pancreatic and salivary isoamylases on starch and glycogen. | 5.36e-06 | 2 | 81 | 2 | 890964 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 11376382 | ||
| Pubmed | MYO7A and USH2A gene sequence variants in Italian patients with Usher syndrome. | 5.36e-06 | 2 | 81 | 2 | 25558175 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 12112664 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 34948090 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 3260028 | ||
| Pubmed | Targeting the IGF1R/PI3K/AKT Pathway Sensitizes Ewing Sarcoma to BET Bromodomain Inhibitors. | 5.36e-06 | 2 | 81 | 2 | 30926641 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 14534255 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 31266775 | ||
| Pubmed | CLINICAL PRESENTATION AND DISEASE COURSE OF USHER SYNDROME BECAUSE OF MUTATIONS IN MYO7A OR USH2A. | 5.36e-06 | 2 | 81 | 2 | 27828912 | |
| Pubmed | Plakoglobin represses SATB1 expression and decreases in vitro proliferation, migration and invasion. | 5.36e-06 | 2 | 81 | 2 | 24260116 | |
| Pubmed | The human amylase-encoding genes amy2 and amy3 are identical to AMY2A and AMY2B. | 5.36e-06 | 2 | 81 | 2 | 2483397 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 15823922 | ||
| Pubmed | Human pancreatic alpha-amylase: phenotypic codominance and new electrophoretic variants. | 5.36e-06 | 2 | 81 | 2 | 309725 | |
| Pubmed | 6.67e-06 | 16 | 81 | 3 | 17567809 | ||
| Pubmed | Beta-catenin is essential for pancreatic acinar but not islet development. | 8.08e-06 | 17 | 81 | 3 | 16192304 | |
| Pubmed | MYOF JUP CAD LNPEP PEG10 CLPTM1 RCN2 CCAR2 TTC17 BSCL2 LARP4 ANKZF1 DNASE2 | 9.03e-06 | 1297 | 81 | 13 | 33545068 | |
| Pubmed | 1.21e-05 | 329 | 81 | 7 | 17474147 | ||
| Pubmed | 1.35e-05 | 20 | 81 | 3 | 1370487 | ||
| Pubmed | The structure of two distinct pancreatic amylase genes in mouse strain YBR. | 1.60e-05 | 3 | 81 | 2 | 2413838 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 6098446 | ||
| Pubmed | The Genetics of Usher Syndrome in the Israeli and Palestinian Populations. | 1.60e-05 | 3 | 81 | 2 | 29490346 | |
| Pubmed | Report of the Committee on the Genetic Constitution of Chromosome 1. | 1.60e-05 | 3 | 81 | 2 | 6360562 | |
| Pubmed | Association of human protein-tyrosine phosphatase kappa with members of the armadillo family. | 1.60e-05 | 3 | 81 | 2 | 8663237 | |
| Pubmed | Tissue-specific and insulin-dependent expression of a pancreatic amylase gene in transgenic mice. | 1.60e-05 | 3 | 81 | 2 | 2436036 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 1699843 | ||
| Pubmed | Two distinct pancreatic amylase genes are active in YBR mice. | 1.60e-05 | 3 | 81 | 2 | 6180955 | |
| Pubmed | Comparative genomic analysis of the mouse and rat amylase multigene family. | 1.60e-05 | 3 | 81 | 2 | 17223109 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 26304632 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 2414282 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 29142287 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 8413315 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 28659346 | ||
| Pubmed | An insulin-responsive element in the pancreatic enhancer of the amylase gene. | 1.60e-05 | 3 | 81 | 2 | 7678001 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 20451170 | ||
| Pubmed | Myoferlin is required for insulin-like growth factor response and muscle growth. | 1.60e-05 | 3 | 81 | 2 | 20008164 | |
| Pubmed | Frequent PTPRK-RSPO3 fusions and RNF43 mutations in colorectal traditional serrated adenoma. | 1.60e-05 | 3 | 81 | 2 | 26924569 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | MYOF JUP IGF1R PTPRK LNPEP AXL CLPTM1 RCN2 TTC17 DOLPP1 BSCL2 DNASE2 | 2.14e-05 | 1201 | 81 | 12 | 35696571 |
| Pubmed | Low Copy Number of the AMY1 Locus Is Associated with Early-Onset Female Obesity in Finland. | 3.20e-05 | 4 | 81 | 2 | 26132294 | |
| Pubmed | Characterization of the amino termini of mouse salivary and pancreatic amylases. | 3.20e-05 | 4 | 81 | 2 | 6165618 | |
| Pubmed | Multiple polyadenylation sites in a mouse alpha-amylase gene. | 3.20e-05 | 4 | 81 | 2 | 6166922 | |
| Pubmed | Structural forms of the human amylase locus and their relationships to SNPs, haplotypes and obesity. | 3.20e-05 | 4 | 81 | 2 | 26098870 | |
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 6160849 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 20939500 | ||
| Pubmed | Electrophoretic variation of alpha-amylase in two inbred strains of Mus musculus. | 3.20e-05 | 4 | 81 | 2 | 4745489 | |
| Pubmed | Gentic polymorphism of amylase isoenzymes in feral populations of the house mouse. | 3.20e-05 | 4 | 81 | 2 | 1141004 | |
| Pubmed | Genetic variation in mouse salivary amylase rate of synthesis. | 3.20e-05 | 4 | 81 | 2 | 94264 | |
| Pubmed | Usher syndromes due to MYO7A, PCDH15, USH2A or GPR98 mutations share retinal disease mechanism. | 3.20e-05 | 4 | 81 | 2 | 18463160 | |
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 3872721 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 6157477 | ||
| Pubmed | Simultaneous expression of salivary and pancreatic amylase genes in cultured mouse hepatoma cells. | 3.20e-05 | 4 | 81 | 2 | 2431276 | |
| Pubmed | Independent regulation of nonallelic pancreatic amylase genes in diabetic mice. | 3.20e-05 | 4 | 81 | 2 | 6207174 | |
| Pubmed | Expression of sulfated gp300 and changes in glycosylation during pancreatic development. | 3.20e-05 | 4 | 81 | 2 | 8543783 | |
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 2410924 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 2476716 | ||
| Pubmed | A single mouse alpha-amylase gene specifies two different tissue-specific mRNAs. | 3.20e-05 | 4 | 81 | 2 | 6162570 | |
| Pubmed | Additional evidence for the close linkage of amy-1 and amy-2 in the mouse. | 3.20e-05 | 4 | 81 | 2 | 6163812 | |
| Pubmed | An amylase/Cre transgene marks the whole endoderm but the primordia of liver and ventral pancreas. | 3.20e-05 | 4 | 81 | 2 | 16786601 | |
| Pubmed | Members of the Amy-2 alpha-amylase gene family of mouse strain CE/J contain duplicated 5' termini. | 3.20e-05 | 4 | 81 | 2 | 2987507 | |
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 6091898 | ||
| Pubmed | Genetic regulation of GM4(NeuAc) expression in mouse erythrocytes. | 3.20e-05 | 4 | 81 | 2 | 2332419 | |
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 2458567 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 6176715 | ||
| Pubmed | Mouse liver and salivary gland alpha-amylase mRNAs differ only in 5' non-translated sequences. | 3.20e-05 | 4 | 81 | 2 | 6162108 | |
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 16152770 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 6161122 | ||
| Pubmed | Expression of mouse Amy-2a alpha-amylase genes is regulated by strong pancreas-specific promoters. | 3.20e-05 | 4 | 81 | 2 | 3877171 | |
| Pubmed | Mouse alpha-amylase loci, Amy-1a and Amy-2a, are closely linked. | 3.20e-05 | 4 | 81 | 2 | 2989529 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | MYOF NEO1 AXL PEG10 CCAR2 BSCL2 STRA6 ALDH5A1 ABCC10 CDH17 WDR72 | 3.49e-05 | 1061 | 81 | 11 | 33845483 |
| Pubmed | 4.16e-05 | 399 | 81 | 7 | 37536630 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MYOF FLNC IGF1R MYO7A RPTOR BRD4 MED14 RNF43 ABCC10 WNK2 SH3BP4 | 5.03e-05 | 1105 | 81 | 11 | 35748872 |
| Pubmed | Voltage-gated potassium channel genes are clustered in paralogous regions of the mouse genome. | 5.22e-05 | 31 | 81 | 3 | 8034307 | |
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 6529441 | ||
| Pubmed | Genetic study of pancreatic proteinase and alpha-amylase in mice (Mus musculus). | 5.33e-05 | 5 | 81 | 2 | 4461036 | |
| Pubmed | Murine Salivary Amylase Protects Against Streptococcus mutans-Induced Caries. | 5.33e-05 | 5 | 81 | 2 | 34276419 | |
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 6176569 | ||
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 1348427 | ||
| Pubmed | Genetic mapping of the IL-12 alpha chain gene (Il12a) on mouse chromosome 3. | 5.33e-05 | 5 | 81 | 2 | 8661735 | |
| Pubmed | Genome-wide association scan for survival on dialysis in African-Americans with type 2 diabetes. | 5.75e-05 | 32 | 81 | 3 | 21546767 | |
| Pubmed | A fibrillar collagen gene, Col11a1, is essential for skeletal morphogenesis. | 7.99e-05 | 6 | 81 | 2 | 7859283 | |
| Pubmed | Regional assignment of human amylase (AMY) to p22----p21 of chromosome 1. | 7.99e-05 | 6 | 81 | 2 | 6608795 | |
| Pubmed | Bromodomain Protein BRD4 Is Essential for Hair Cell Function and Survival. | 7.99e-05 | 6 | 81 | 2 | 33015071 | |
| Pubmed | Purkinje cell degeneration associated with erythroid ankyrin deficiency in nb/nb mice. | 7.99e-05 | 6 | 81 | 2 | 1716634 | |
| Pubmed | 7.99e-05 | 6 | 81 | 2 | 2002257 | ||
| Pubmed | 7.99e-05 | 6 | 81 | 2 | 2450406 | ||
| Pubmed | 7.99e-05 | 6 | 81 | 2 | 2452973 | ||
| Pubmed | The human alpha-amylase multigene family consists of haplotypes with variable numbers of genes. | 7.99e-05 | 6 | 81 | 2 | 2788608 | |
| Pubmed | 7.99e-05 | 6 | 81 | 2 | 7946325 | ||
| Pubmed | Ampd-2 maps to distal mouse chromosome 3 in linkage with Ampd-1. | 7.99e-05 | 6 | 81 | 2 | 2328996 | |
| Pubmed | Genetics of hydroxyacid oxidase isozymes in the mouse: localisation of Hao-2 on linkage group XVI. | 7.99e-05 | 6 | 81 | 2 | 284003 | |
| Pubmed | 7.99e-05 | 6 | 81 | 2 | 2081604 | ||
| Pubmed | 7.99e-05 | 6 | 81 | 2 | 15286789 | ||
| Pubmed | Localization of the 70-kDa peroxisomal membrane protein to human 1p21-p22 and mouse 3. | 7.99e-05 | 6 | 81 | 2 | 8449508 | |
| Pubmed | An unmethylated 3' promoter-proximal region is required for efficient transcription initiation. | 7.99e-05 | 6 | 81 | 2 | 17305432 | |
| Pubmed | The mouse urate oxidase gene, Uox, maps to distal chromosome 3. | 7.99e-05 | 6 | 81 | 2 | 9250879 | |
| Pubmed | Linkage of the cadmium resistance locus to loci on mouse chromosome 12. | 7.99e-05 | 6 | 81 | 2 | 1021597 | |
| Interaction | NPHS2 interactions | 4.86e-06 | 64 | 78 | 5 | int:NPHS2 | |
| Cytoband | 1p21 | 8.27e-04 | 24 | 81 | 2 | 1p21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q24 | 1.34e-03 | 122 | 81 | 3 | chr15q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q25 | 3.28e-03 | 167 | 81 | 3 | chr1q25 | |
| GeneFamily | Fibronectin type III domain containing | NPHS1 FNDC1 NEO1 IGF1R MYLK PTPRK ELFN1 AXL PTPRQ NFASC ROBO2 ROS1 USH2A | 2.18e-15 | 160 | 57 | 13 | 555 |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.52e-04 | 161 | 57 | 5 | 593 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 2.70e-04 | 40 | 57 | 3 | 321 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 1.97e-03 | 21 | 57 | 2 | 813 | |
| GeneFamily | Immunoglobulin like domain containing | 3.20e-03 | 193 | 57 | 4 | 594 | |
| GeneFamily | CD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing | 7.75e-03 | 42 | 57 | 2 | 602 | |
| Coexpression | BERGER_MBD2_TARGETS | 4.44e-06 | 11 | 80 | 3 | MM905 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.35e-06 | 336 | 79 | 9 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000 | |
| CoexpressionAtlas | pancreas | 6.28e-06 | 70 | 79 | 5 | pancreas | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000 | 6.43e-06 | 265 | 79 | 8 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.00e-05 | 310 | 79 | 8 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000 | PAPPA2 FLNC NEO1 PNLIPRP1 SATB1 HMCN1 PTPRK ADAMTS3 AXL PEG10 ROBO2 SVEP1 | 5.48e-05 | 831 | 79 | 12 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 1.23e-04 | 207 | 79 | 6 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | PAPPA2 MYOF FLNC MYLK SATB1 HMCN1 ADAMTS3 AXL PEG10 ROBO2 SVEP1 | 1.31e-04 | 773 | 79 | 11 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | PAPPA2 MYOF FLNC NEO1 PNLIPRP1 SATB1 HMCN1 ADAMTS3 AXL PEG10 ROBO2 | 1.71e-04 | 797 | 79 | 11 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_500 | 1.76e-04 | 423 | 79 | 8 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.84e-04 | 223 | 79 | 6 | Facebase_RNAseq_e9.5_Facial Mesenchyne_1000_K4 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 2.15e-04 | 146 | 79 | 5 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.60e-04 | 337 | 79 | 7 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#2 | 3.33e-04 | 249 | 79 | 6 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_1000_K2 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.49e-04 | 354 | 79 | 7 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_1000 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 6.60e-08 | 194 | 81 | 7 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.08e-08 | 196 | 81 | 7 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.08e-08 | 196 | 81 | 7 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.13e-08 | 200 | 81 | 7 | 87827041663013f5e7273168dc8709d69840e7ce | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Col23a1_Adamts2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.27e-07 | 65 | 81 | 5 | f14b28214f80ed23501ab28ff254c206f70d77b2 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-07 | 158 | 81 | 6 | 12661763d1c309106801cb710c04cd2b62d16cba | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-epithelial_cell_of_thymus|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-07 | 158 | 81 | 6 | e7db50d6dfaf7280a73a0d5b5aa4f43ea2762d72 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-07 | 158 | 81 | 6 | 0792c39e6fc0745095af7812de2d50949540d60f | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.79e-07 | 160 | 81 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.79e-07 | 160 | 81 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.16e-07 | 162 | 81 | 6 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | mild_COVID-19_(asymptomatic)-cDC|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 7.57e-07 | 173 | 81 | 6 | 71dc0051c87b84e3cf13cde8858166f2a474b5dc | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.24e-07 | 179 | 81 | 6 | 7394e77e665bf16d3733df91bb12907be460ab44 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.86e-07 | 181 | 81 | 6 | 5bf7aa43f6e6ecce15c95928b91195544d6928c4 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.86e-07 | 181 | 81 | 6 | 8e751f5d7cd2d328ec0196d874e8a507e8c4e1a9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-06 | 183 | 81 | 6 | 848fc6dd129150897ee339343e83c645b6e779eb | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-06 | 183 | 81 | 6 | 7c4b775f351794a3de06bd503eecbc8ae8577c44 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 1.08e-06 | 184 | 81 | 6 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-06 | 191 | 81 | 6 | 9032aa974aa1b7b1095b8d1b58dcb087358a5001 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-06 | 191 | 81 | 6 | 5717809a1476c20f65bce722c5a57cff92ee0d7a | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 1.43e-06 | 193 | 81 | 6 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | PND07-28-samps-Mesenchymal|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.48e-06 | 194 | 81 | 6 | 68bcc1fe8dc8d5f23a12154fc9b41362fdef0b1d | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 1.76e-06 | 200 | 81 | 6 | 593bf6a7c557437db9a9249a5058a46014179ef6 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.83e-06 | 145 | 81 | 5 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.86e-06 | 153 | 81 | 5 | c1335e7d7407412431ed4d8c7dfcb2c6086d8483 | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell|Adult / Lineage, Cell type, age group and donor | 1.35e-05 | 167 | 81 | 5 | d584a8548a5317bd9686b3be8246ae6ed568796b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-05 | 168 | 81 | 5 | fc80e4fecfc92458eb627013a983041d8ca025a9 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-G|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.39e-05 | 168 | 81 | 5 | 8c95093b1ea45826f62893edd3c410fe53b563a4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-05 | 168 | 81 | 5 | 315ca578c945aeeb77acda2727f3e6db8b43f43e | |
| ToppCell | 367C-Fibroblasts-Fibroblast-G-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.39e-05 | 168 | 81 | 5 | b8c65542a0701ae31f49d332d87a64578e24b4e3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-05 | 168 | 81 | 5 | e96859dbf51cf8c4def8ee8db132f4d874fb4381 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-05 | 172 | 81 | 5 | 6c17a1e586a72d1bd80c20c06370429c61dc9f85 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-05 | 172 | 81 | 5 | 381ae1c3c07d0a424f43455ec571653b192a946a | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-05 | 173 | 81 | 5 | fc2602b2ce051cd4c33957d7e3d041ff8a529883 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-05 | 173 | 81 | 5 | 901b8e6909c1f3849906fad9cee17b8f0bab050d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.65e-05 | 174 | 81 | 5 | b3cd22e717d178269e6d5bd5ed7b2d945cd8ea25 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.65e-05 | 174 | 81 | 5 | dbdcdec08f1fc69fcdb5d8a6d78df8ef9c374d89 | |
| ToppCell | COVID-19-kidney-Podocyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.70e-05 | 175 | 81 | 5 | a73e3a65fd5c1e09cb0c2dae20c1a7bfcae49223 | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-05 | 175 | 81 | 5 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.74e-05 | 176 | 81 | 5 | b0b87eebcf5c994386b39ca607e17f10e9d9de74 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.79e-05 | 177 | 81 | 5 | 84116796ca4c7007508c0f1a68a1135c7b922278 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.79e-05 | 177 | 81 | 5 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.79e-05 | 177 | 81 | 5 | 4d2cdb57b427a42085c5f9affa0967b15e84dec3 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.79e-05 | 177 | 81 | 5 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L5-6_THEMIS_TMEM233|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.84e-05 | 178 | 81 | 5 | c655b72ec22d45d2da69c2d8886a01831ce79558 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.84e-05 | 178 | 81 | 5 | edc7143dc9959d36057cb9471681a23afcbc8cce | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L5-6_THEMIS_TMEM233|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.89e-05 | 179 | 81 | 5 | 747a32460b257fffca30527b56a74720eb9c12e4 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.94e-05 | 180 | 81 | 5 | d685fa2b013bc085dbef7c40956ed3043f83e483 | |
| ToppCell | mild_COVID-19_(asymptomatic)-cDC|World / disease group, cell group and cell class (v2) | 1.94e-05 | 180 | 81 | 5 | 68d1c867734fb2977b01ac686b20bf602f9a6b72 | |
| ToppCell | facs-Pancreas-Exocrine-24m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-05 | 180 | 81 | 5 | 72310baeed848f2c483ae986cd73d2fb2cca7feb | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.99e-05 | 181 | 81 | 5 | 9c157de9d3403e092c907599f2a2c16db5b21131 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.99e-05 | 181 | 81 | 5 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 1.99e-05 | 181 | 81 | 5 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.99e-05 | 181 | 81 | 5 | eea943fdcbef0bbaa8578f3296923e874893b405 | |
| ToppCell | COVID-19-kidney-Podocyte|kidney / Disease (COVID-19 only), tissue and cell type | 2.10e-05 | 183 | 81 | 5 | fb5e2a31b560126e1c04a386c24c365901c60ad7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.10e-05 | 183 | 81 | 5 | 612d93df03252d4d2ccdce5a9bc162cfd9172a1a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.10e-05 | 183 | 81 | 5 | eb559ae3ae252d9365c24ef557dd49b78ed6d898 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.10e-05 | 183 | 81 | 5 | bc7dd6a40ec9c773d005c1a46f305d40cdd0a326 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 184 | 81 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | mild-Myeloid-mDC|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.16e-05 | 184 | 81 | 5 | 8b37c00d59d9992d3b43268991da7bb94646c70e | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 184 | 81 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 184 | 81 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.21e-05 | 185 | 81 | 5 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium_(RGS5+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.21e-05 | 185 | 81 | 5 | 11fbea1eb1d9a3e4480d0d2b0f7b02e2866b8142 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 2.33e-05 | 187 | 81 | 5 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | droplet-Pancreas|droplet / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-05 | 187 | 81 | 5 | 5f4df092452d8672bda4059c794e099ba3f5a8fa | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 2.33e-05 | 187 | 81 | 5 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.39e-05 | 188 | 81 | 5 | b2d68a32314e9b099ed74d974079ad96359d1ae3 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.39e-05 | 188 | 81 | 5 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | Mesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 2.52e-05 | 190 | 81 | 5 | 645e56b02edc3702c7db917b8ecd5eed0decaf71 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 2.52e-05 | 190 | 81 | 5 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.58e-05 | 191 | 81 | 5 | 5343a527de6b0f852f45020a91f5b4869e78f13a | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.58e-05 | 191 | 81 | 5 | a25a5f9a380031fdaf57677a079f97a90f0550c0 | |
| ToppCell | ASK440-Mesenchymal|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.58e-05 | 191 | 81 | 5 | f12959eebb4167e1aa03de05d7711a702c58b3c9 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.58e-05 | 191 | 81 | 5 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | ASK440-Mesenchymal-Fibroblast|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.58e-05 | 191 | 81 | 5 | 387296b5377ef6839f0812e5b3529a10b5f7d530 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.58e-05 | 191 | 81 | 5 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.65e-05 | 192 | 81 | 5 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.71e-05 | 193 | 81 | 5 | 7cd9671e0ac64f7f3607f564485c63abbb7e7a63 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.71e-05 | 193 | 81 | 5 | cf2461af78f65616ce40d552ee9452295e3895ed | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.71e-05 | 193 | 81 | 5 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 2.71e-05 | 193 | 81 | 5 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.71e-05 | 193 | 81 | 5 | 6ef9007c9d18fb775d08fb20cdf954a28d54d7eb | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.71e-05 | 193 | 81 | 5 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.71e-05 | 193 | 81 | 5 | e4ea7ce011a80b81b841c907719aa532bed39d2e | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.78e-05 | 194 | 81 | 5 | 8fae8061b350336299aa81f378e07deadbd55123 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.78e-05 | 194 | 81 | 5 | 4d7d24390fdb379f943ddcc70a63f23955e10163 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.78e-05 | 194 | 81 | 5 | ebb038f94f49f5c655578d1b018676e10c6b7e3c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.85e-05 | 195 | 81 | 5 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.85e-05 | 195 | 81 | 5 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 2.85e-05 | 195 | 81 | 5 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 2.85e-05 | 195 | 81 | 5 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | Fibroblast-B_(Myofibroblast)|World / shred on cell class and cell subclass (v4) | 2.85e-05 | 195 | 81 | 5 | a8d6416518f226e1ec2d6bdc9d4b90cef5cb1365 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.85e-05 | 195 | 81 | 5 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.92e-05 | 196 | 81 | 5 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.92e-05 | 196 | 81 | 5 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-05 | 196 | 81 | 5 | 2029f58ce6a7b8c35d3a7496c3341391990909ce | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.92e-05 | 196 | 81 | 5 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.99e-05 | 197 | 81 | 5 | 26475b9e4d6bfc0ae818dea13d139888ed7e92f1 | |
| ToppCell | normal_Lung-Fibroblasts-COL13A1+_matrix_FBs|normal_Lung / Location, Cell class and cell subclass | 2.99e-05 | 197 | 81 | 5 | 6c57ab2efb8363828e24211c4d45e58bb73a9a4d | |
| Disease | carbamoyl phosphate synthetase I deficiency disease (implicated_via_orthology) | 6.72e-06 | 2 | 77 | 2 | DOID:9280 (implicated_via_orthology) | |
| Disease | Usher syndrome type 2 | 2.01e-05 | 3 | 77 | 2 | C0339534 | |
| Disease | Usher syndrome (is_implicated_in) | 4.02e-05 | 4 | 77 | 2 | DOID:0050439 (is_implicated_in) | |
| Disease | coronary artery disease | FNDC1 CEL ADAMTS3 LNPEP ELFN1 RPTOR ALDH5A1 SVEP1 ABCC10 WNK2 CDH17 WDR72 | 5.90e-05 | 1194 | 77 | 12 | EFO_0001645 |
| Disease | Usher Syndrome, Type II | 6.69e-05 | 5 | 77 | 2 | C1568249 | |
| Disease | chronic mucus hypersecretion | 1.40e-04 | 7 | 77 | 2 | EFO_0005673 | |
| Disease | clear cell renal cell carcinoma (is_implicated_in) | 1.86e-04 | 8 | 77 | 2 | DOID:4467 (is_implicated_in) | |
| Disease | Liver Diseases, Parasitic | 2.39e-04 | 9 | 77 | 2 | C0023897 | |
| Disease | alpha-amylase 1 measurement | 2.39e-04 | 9 | 77 | 2 | EFO_0801371 | |
| Disease | essential tremor | 4.50e-04 | 136 | 77 | 4 | EFO_0003108 | |
| Disease | renal cell carcinoma (biomarker_via_orthology) | 5.99e-04 | 14 | 77 | 2 | DOID:4450 (biomarker_via_orthology) | |
| Disease | body surface area | 1.45e-03 | 643 | 77 | 7 | EFO_0022196 | |
| Disease | serum urea measurement | 1.72e-03 | 195 | 77 | 4 | EFO_0009795 | |
| Disease | Intrahepatic Cholangiocarcinoma | 1.79e-03 | 24 | 77 | 2 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 1.79e-03 | 24 | 77 | 2 | C3805278 | |
| Disease | response to perphenazine | 2.10e-03 | 26 | 77 | 2 | GO_0097334 | |
| Disease | Cholangiocarcinoma | 2.10e-03 | 26 | 77 | 2 | C0206698 | |
| Disease | Pancreatic Neoplasm | 2.30e-03 | 100 | 77 | 3 | C0030297 | |
| Disease | mean corpuscular hemoglobin concentration | 2.31e-03 | 1105 | 77 | 9 | EFO_0004528 | |
| Disease | blood cobalt measurement | 2.37e-03 | 101 | 77 | 3 | EFO_0007577 | |
| Disease | Malignant neoplasm of pancreas | 2.44e-03 | 102 | 77 | 3 | C0346647 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NPGQAVPWNAVKVQT | 101 | Q8N163 | |
| LLANSKVEPIPWNQA | 106 | P00813 | |
| KGFVWLAICSQNQPP | 36 | P0C7U0 | |
| WPFQQPVDAVKLNLP | 81 | O60885 | |
| PLLDSVAQQQGAWLP | 136 | Q9GZQ3 | |
| DWVGPPNNNGVIKEV | 371 | P19961 | |
| GVALSPWVIQKNPLF | 241 | P19835 | |
| RLAPPVQWALQVQGN | 101 | Q86SI9 | |
| ELLPWVVPNNQGIAQ | 251 | Q14257 | |
| PQPQLANGALKVSVW | 11 | Q9BUV8 | |
| DWVGPPNNNGVIKEV | 371 | P04746 | |
| VWKGIPQAPQGAFIS | 516 | Q9Y5R2 | |
| ILPLVQAVPKAWAEN | 811 | Q5T3U5 | |
| NPLATLQWLKNGQPV | 271 | O60500 | |
| GKFVGLPPQWQNILD | 31 | Q9NQU5 | |
| QVTWLKGNVPLQPSA | 191 | Q15746 | |
| WLETCNAPPQLIQGK | 96 | Q9H6Y5 | |
| GVNWLIKNVIQEPRP | 71 | Q86YN1 | |
| AAPVKWIFQDNLQPF | 286 | Q5T3J3 | |
| QKVSGGEQPIPLWNE | 3126 | Q2LD37 | |
| QLIVKWNPPSLPNGN | 626 | P08069 | |
| VKFLWNNNVINPTLP | 416 | P54315 | |
| EDAKPGQFPWQVVLN | 231 | P00740 | |
| LGWIQNKVPQLPITN | 166 | Q14315 | |
| APNGAQVLQVKRGWK | 576 | Q86TG7 | |
| IQPFATNGKLFPWAQ | 151 | Q9UIQ6 | |
| PVVKNPPNNLWIIAA | 1171 | Q6ZVL6 | |
| GIPAIVKLLNQPNQW | 481 | P14923 | |
| QPNQWPLVKATIGLI | 491 | P14923 | |
| KNVLQWTPPEGLQGV | 51 | Q9UHF4 | |
| NIQVPPSFQKLWEIG | 2761 | Q96RW7 | |
| LQLKVTPENAGQWKP | 1261 | O60244 | |
| AINVSWVPPAQPNGL | 1111 | Q9UMZ3 | |
| LVCRANGNPKPTVQW | 356 | O94856 | |
| AWVKPEGGQNNPAII | 291 | Q9BXP8 | |
| PAGWKPLFVNVNDQT | 346 | P31327 | |
| KPNTQLVAPGAVVEW | 96 | O15072 | |
| TGLAQVLLQWKPNPD | 41 | Q01344 | |
| WQVLNVNQIAFPGPA | 271 | O00115 | |
| INWDAINKNQVPPPS | 371 | Q6E0U4 | |
| AKAPGQPELWNALLA | 486 | Q9H8Y5 | |
| LNVWPVNGKPTVVAA | 366 | Q4ZHG4 | |
| PVNPWKTNNVLQPGE | 1756 | O75417 | |
| VENAILIKNGQQWPL | 2511 | Q0VDD8 | |
| NPNAKVWQEIAPGNT | 16 | Q71RC2 | |
| QQWPAKVPVPRGADQ | 166 | Q8NA82 | |
| PVPALLWAQEVGQVL | 6 | Q96G97 | |
| PIKITQVRWNDPGAQ | 256 | Q12864 | |
| LAAAPPQGLKNWEVV | 76 | D6RIA3 | |
| LVRVNKGPLANPIWN | 126 | Q15262 | |
| QVTWKPPLIQNGDIL | 2741 | O75445 | |
| LKQPIGVAAVITPWN | 191 | P51649 | |
| PAPVALQLWGKHQFV | 516 | Q9P0V3 | |
| ARWFQQKPGQAPVLV | 51 | P01718 | |
| WKPLQGVGNLAAPNA | 1226 | P30414 | |
| ASKQLWNPPQVQGPL | 796 | Q92540 | |
| KTIIVNWQPPSEANG | 971 | Q92859 | |
| AAAEQLQQPLGLTWP | 146 | Q68DV7 | |
| NSQLLCNAQGKWVPP | 2056 | Q4LDE5 | |
| QGPSVLKCLPSQQWN | 2356 | Q4LDE5 | |
| PRPTVNGEVWVFNKN | 156 | Q8N122 | |
| AQAKGLIQVGKWNPV | 126 | Q01826 | |
| VQVWQRAECPQVPKI | 186 | Q9BX79 | |
| LQVPQGWAVLTGPQQ | 651 | P0C7V6 | |
| PPLFGWAQNVNDDKV | 216 | P34969 | |
| VNCVAWNPKEPGLLA | 306 | O76071 | |
| AQPAPNAWQVIKGVL | 46 | O96005 | |
| GNIKAPSLQAWNDAP | 296 | Q9UJ71 | |
| PVAQPAKSWDPNQLN | 711 | A6PVC2 | |
| PVKTPVLEQWQRNGF | 151 | P52742 | |
| QAVALWGQKAPPHSI | 6 | Q3MJ13 | |
| WRPGQAQPVHQLVKE | 426 | P30530 | |
| WKPETPQANLAINPA | 931 | Q9Y4E1 | |
| PQPAVFWQKEGSQNL | 341 | Q9HCK4 | |
| QWKPPALAIGANVIL | 576 | P08922 | |
| QTQPVPWKGTVVLFN | 406 | Q86VD9 | |
| INKPNAPIWLILNEA | 611 | Q96AE7 | |
| GQDVRKWPQGAVPQL | 1806 | P27708 | |
| PIPIQGSWAKAFVNQ | 181 | Q9UJW7 | |
| WQLKAPVPAGQKELN | 491 | P51687 | |
| IWPALQPKEQQDVGS | 546 | Q9Y3S1 | |
| ITNQWEAVAPLPKAV | 706 | Q96CT2 | |
| AGGWQLVAVDVNKPQ | 356 | Q8IZF0 | |
| GPSLPKNDVIVAVNW | 1481 | Q13402 | |
| NGPKVPVELRVNIWL | 826 | Q9NZM1 |